The implantable cardioverter defibrillator (ICD) is today an indisputable evidence-based treatment for cardiac sudden death both in primary and secondary prevention. However many clinical conditions that would represent an indication to ICD implantation, according to guidelines, may be potentially reversible or may be accompanied by temporary contraindications to the implant. Moreover transvenous cardioverter defibrillator implantation still carries a not negligible risk of complications both acutely and at follow-up. The Wearable Cardioverter Defibrillator and the Subcutaneous Defibrillator are two recently developed technologies that can potentially overcome the aforementioned limitations of traditional transvenous ICDs. This review will discuss the main aspects of these 2 technologies, the data coming from clinical experiences and future perspectives.

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0026-4725.17.04468-1DOI Listing

Publication Analysis

Top Keywords

cardioverter defibrillator
16
defibrillator
5
prevention sudden
4
sudden cardiac
4
cardiac death
4
death wearable
4
wearable subcutaneous
4
cardioverter
4
subcutaneous cardioverter
4
defibrillator implantable
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!